Prescription drug · ANDA
Brivaracetam oral Solution (Brivaracetam oral) NDC 71921-410
Brivaracetam 10 mg/mL · Solution · Oral · Florida Pharmaceutical Products, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71921-410-72 | 71921041072 | 1 BOTTLE in 1 CARTON (71921-410-72) / 300 mL in 1 BOTTLEMarketed from Feb 24, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Brivaracetam oral Solution
- Generic name (nonproprietary)
- brivaracetam oral
- Active ingredients
- Brivaracetam — 10 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Florida Pharmaceutical Products, LLCNDC labeler code 71921
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 220385
- Marketing start
- Listing expires
- DEA schedule
- CV
- Other FDA classes
- Epoxide Hydrolase Inhibitors (Mechanism)
- Identifiers
- Product ID 71921-410_7957cc22-2e0f-489d-9fa1-99520f615934SPL ID 7957cc22-2e0f-489d-9fa1-99520f615934SPL set ID 7957cc22-2e0f-489d-9fa1-99520f615934RxCUI 1739785UNII U863JGG2IAUPC 0371921410729
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471921041072followed by a unit qualifier and the quantityPackage 71921-0410-72. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Brivaracetam oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 71921-410
- What is NDC 71921-410?
- 71921-410 is the product NDC for Brivaracetam oral Solution (brivaracetam oral), Brivaracetam 10 mg/mL solution, listed with the FDA by Florida Pharmaceutical Products, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Brivaracetam oral Solution (Brivaracetam oral).
- What is the active ingredient?
- Brivaracetam.
- Who is the labeler?
- Florida Pharmaceutical Products, LLC, NDC labeler code 71921. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Brivaracetam oral Solution?
- 1 other product NDC are listed under this name. See all Brivaracetam oral Solution NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Brivaracetam oral Solution products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Brivaracetam Oral Solutionbrivaracetam | Brivaracetam 10 mg/mL | SolutionOral | Ascend Laboratories, LLC | 67877-904 | 67877-0904-58 |